Schedule 13G ownership disclosure

BioMarin Pharmaceutical Inc

Security class unavailable · CUSIP: 09061G101

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,177,000
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000004405-19-000001
Form type
SC 13G
Filer
AMCAP FUND
CIK
CIK 4405
Filed
Feb 14, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub